New oral painkiller aims to ease recovery after abdominal surgery

NCT ID NCT07709598

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This clinical trial tests an experimental painkiller called HL-1186 for people recovering from abdominal surgery. The study compares HL-1186 to a placebo and to a standard painkiller (oxycodone-acetaminophen) to see how well it controls pain and whether it is safe. Participants are adults aged 18 to 75 who are scheduled for abdominal surgery under general anesthesia and are expected to have moderate to severe pain afterward.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an experimental painkiller called HL-1186
What this could lead to
If effective, HL-1186 could offer a new oral option for managing pain after abdominal surgery, potentially with fewer side effects than current treatments.
What could go wrong
This is a mid-stage trial with 330 participants, so results may not apply to everyone. The drug could prove no better than existing painkillers or cause unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sichuan Provincial People's Hospital

    RECRUITING

    Chengdu, Sichuan, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.